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cable. This effect was taken into account during treatment 
planning. Position verification using the PermaDoc phantom 
confirmed this 1 mm retraction. All radiographically 
measured dead spaces complied with the specifications, 
except for the plastic needles which were 1 mm shorter than 
indicated. The center of the active source is at 2.42 mm from 
the tip of the capsule. Combined with the 1 mm source 
retraction, the center of the dose distribution at the most 
distal position located always 3.5 mm behind the internal 
end-point of the source channel. Radiographic and dosimetric 
dead space measurements showed good agreement (<0.5mm) 
for all applicators.  
 
 
 
Conclusion: Measured source position and dwell time 
accuracy comply with the vendor’s specifications. Small 
deviations were found for the dwell time accuracy at the 
most proximal source position. Similar tests should be 
performed regularly to warrant the mechanical accuracy of 
the afterloader and the quality of the applicators and 
transfer tubes.  
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Purpose or Objective: Dose verification and quality 
assurance in radiotherapy (RT) should be assessed in order to 
provide the best treatment possible and minimize risks for 
patient. In certain treatments there are no tools capable of 
performing real-time dose measurement. In addition, in-situ 
real-time dosimetry would enhance brachytherapy (BT) by 
providing technical conditions to perform treatment 
readjustment and real-time dose correction. Considering the 
current challenges, we developed a dosimeter intended for 
in-situ and real-time dosimetry in High Dose Rate 
brachytherapy (HDR-BT), e.g., prostate and breast. 
 
Material and Methods: The dosimeter developed has a 
sensitive 3 m long optical fiber probe of 1mm or 0.5 mm 
diameter comprehending a 5 mm length scintillating optical 
fiber. To read the signal produced at the probe, 1x1 mm2 
Silicon Photomultipliers (SiPM) from Hamamatsu were used. A 
custom made readout system with SiPM temperature 
compensation was used. The main concerns when performing 
dosimetry at high dose rates with high energy isotopes is the 
eventuality of Cherenkov light production. This form of noise 
accounts to the total noise signal, known as stem effect. 
The dosimeter was placed in a PMMA phantom and the 
response was evaluated with a 10.07 Ci Ir-192 HDR-
brachytherapy source (Nucletron). Measurements were 
repeated twice, first using a dummy probe without 
scintillator for stem effect quantification and second using an 
ionization chamber (IC) read by an electrometer for 
reference. 
Results: The studies carried out allowed assessing the 
amount of stem effect produced in the optical fiber cable. In 
the conditions described above, the stem effect contribution 
is lower than 1% for both 0.5 and 1 mm probes. The 
measurements of the fiber dosimeter response as a function 
of the dose are represented in Figure 1. The small difference 
from the reference IC is due to the different detector 
volumes of the fiber dosimeter and the ionization chamber. 
The dosimeter shows a linear response with dose rate being 
capable of detecting µGy dose variations. 
 
 
 
Figure 1: Fiber optic dosimeter stem-effect and response for 
0.5 and 1 mm diameter versions compared to ionization 
chamber response. 
 
Conclusion: The first round of in-vitro tests in clinical setting 
demonstrated that the fiber optical based dosimeters 
developed are suitable for dosimetry in regimes such as HDR 
prostate BT. The versatility of this kind of device and 
easiness of use allows application in other radiotherapy 
modalities. Besides fulfilling all the requirements for a 
dosimeter in HDR-BT, the high sensitivity of this device 
makes it a suitable candidate for application in LDR-BT.  
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Purpose or Objective: An intraoperatively built custom-
linked (IBCL) seeds system is a push-button seed delivery 
system that allows the user to create intraoperatively 
customized linked seeds, using a combination of seeds, 
connectors, and spacers. To date, only three studies have 
compared the implant quality of IBCL seeds to loose seeds for 
use in permanent prostate brachytherapy (PPB). However, 
they did not use sector analysis. Therefore, we compared the 
implant quality of IBCL seeds to loose seeds in PPB using 
sector analysis. 
 
Material and Methods: Between June 2012 and January 2015, 
64 consecutive prostate cancer patients underwent 
brachytherapy with IBCL seeds (n = 32) or loose seeds (n = 
32). All the patients were treated with 144Gy of 
brachytherapy alone. IBCL and loose seeds were alternately 
used basically. All patients were treated by the same 
radiation oncologist and urologist. We used the same dose–
